260 related articles for article (PubMed ID: 27930715)
1. Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases.
Fujio N; Masuoka S; Shikano K; Kusunoki N; Nanki T; Kawai S
PLoS One; 2016; 11(12):e0167854. PubMed ID: 27930715
[TBL] [Abstract][Full Text] [Related]
2. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
[TBL] [Abstract][Full Text] [Related]
3. [Influence of interleukin-1 and interleukin-6 on modulation of hypothalamo-pituitary-adrenal axis in pregnancy at term and in spontaneous and oxytocin-induced delivery].
Ochedalski T; Lachowicz A
Ginekol Pol; 2003 Oct; 74(10):1228-35. PubMed ID: 14669422
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
Cutolo M; Foppiani L; Minuto F
J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of the hypothalamic-hypophyseal-adrenal axis in patients with chronic obstructive lung disease. Comparison of inhalant with systemic glucocorticoid therapy].
Santen RT; Schlaghecke R; Schwalen A
Dtsch Med Wochenschr; 1997 Apr; 122(16):497-503. PubMed ID: 9162622
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
Dinan TG; Quigley EM; Ahmed SM; Scully P; O'Brien S; O'Mahony L; O'Mahony S; Shanahan F; Keeling PW
Gastroenterology; 2006 Feb; 130(2):304-11. PubMed ID: 16472586
[TBL] [Abstract][Full Text] [Related]
7. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER
J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
[TBL] [Abstract][Full Text] [Related]
8. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids.
Gudbjörnsson B; Skogseid B; Oberg K; Wide L; Hällgren R
J Rheumatol; 1996 Apr; 23(4):596-602. PubMed ID: 8730111
[TBL] [Abstract][Full Text] [Related]
9. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
[TBL] [Abstract][Full Text] [Related]
10. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
Härle P; Straub RH; Wiest R; Mayer A; Schölmerich J; Atzeni F; Carrabba M; Cutolo M; Sarzi-Puttini P
Ann Rheum Dis; 2006 Jan; 65(1):51-6. PubMed ID: 15941834
[TBL] [Abstract][Full Text] [Related]
11. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor.
Zietz B; Reber T; Oertel M; Glück T; Schölmerich J; Straub RH
J Rheumatol; 2000 Apr; 27(4):911-8. PubMed ID: 10782815
[TBL] [Abstract][Full Text] [Related]
12. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids.
Cutolo M; Foppiani L; Prete C; Ballarino P; Sulli A; Villaggio B; Seriolo B; Giusti M; Accardo S
J Rheumatol; 1999 Feb; 26(2):282-8. PubMed ID: 9972959
[TBL] [Abstract][Full Text] [Related]
14. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
[TBL] [Abstract][Full Text] [Related]
15. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
[TBL] [Abstract][Full Text] [Related]
16. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis.
Kirwan JR; Hickey SH; Hällgren R; Mielants H; Björck E; Persson T; Wollheim FA
Arthritis Rheum; 2006 May; 54(5):1415-21. PubMed ID: 16645969
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
[TBL] [Abstract][Full Text] [Related]
18. Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in rheumatoid arthritis.
Mastorakos G; Ilias I
Z Rheumatol; 2000; 59 Suppl 2():II/75-9. PubMed ID: 11155809
[TBL] [Abstract][Full Text] [Related]
19. Inappropriately normal plasma ACTH and cortisol concentrations in the face of increased circulating interleukin-6 concentration in exercise in patients with sarcoidosis.
Mastorakos G; Paltoglou G; Greene M; Ilias I; Papamichalopoulos A; Dimopoulos S; Pouliou E; Fatouros IG; Nanas S
Stress; 2013 Mar; 16(2):202-10. PubMed ID: 22871212
[TBL] [Abstract][Full Text] [Related]
20. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.
Schlaghecke R; Kornely E; Santen RT; Ridderskamp P
N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
